113 related articles for article (PubMed ID: 28353353)
1. Risk of Malignancy in Thyroid Incidentaloma is Not Increased in Overweight or Obese Patients, but in Young Patients.
Pak K; Shin S; Kim SJ; Kim K; Kim BS; Kim SJ; Jeon YK; Kim SS; Kim BH; Kim IJ
Nutr Cancer; 2017; 69(4):580-584. PubMed ID: 28353353
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and risk of cancer of thyroid incidentaloma identified by fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.
Yang Z; Shi W; Zhu B; Hu S; Zhang Y; Wang M; Zhang J; Yao Z; Zhang Y
J Otolaryngol Head Neck Surg; 2012 Oct; 41(5):327-33. PubMed ID: 23092835
[TBL] [Abstract][Full Text] [Related]
3. Body mass index in the evaluation of thyroid cancer risk.
Mijović T; How J; Pakdaman M; Rochon L; Gologan O; Hier MP; Black MJ; Young J; Tamilia M; Payne RJ
Thyroid; 2009 May; 19(5):467-72. PubMed ID: 19415996
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects.
Kang KW; Kim SK; Kang HS; Lee ES; Sim JS; Lee IG; Jeong SY; Kim SW
J Clin Endocrinol Metab; 2003 Sep; 88(9):4100-4. PubMed ID: 12970270
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of thyroid fluorodeoxyglucose-whole body positron emission tomography incidentaloma.
Van den Bruel A; Maes A; De Potter T; Mortelmans L; Drijkoningen M; Van Damme B; Delaere P; Bouillon R
J Clin Endocrinol Metab; 2002 Apr; 87(4):1517-20. PubMed ID: 11932274
[TBL] [Abstract][Full Text] [Related]
6. Thyroid incidentaloma.
Jin J; McHenry CR
Best Pract Res Clin Endocrinol Metab; 2012 Feb; 26(1):83-96. PubMed ID: 22305454
[TBL] [Abstract][Full Text] [Related]
7. Incidental thyroid lesions on FDG-PET/CT: a prevalence study and proposition of management.
Adas M; Adas G; Koc B; Ozulker F
Minerva Endocrinol; 2015 Sep; 40(3):169-75. PubMed ID: 26205646
[TBL] [Abstract][Full Text] [Related]
8. Thyroid incidentaloma as a "PAIN" phenomenon- does it always require surgery?
Kaliszewski K; Diakowska D; Ziętek M; Knychalski B; Aporowicz M; Sutkowski K; Wojtczak B
Medicine (Baltimore); 2018 Dec; 97(49):e13339. PubMed ID: 30544397
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for cancer screening in healthy subjects.
Chen YK; Ding HJ; Chen KT; Chen YL; Liao AC; Shen YY; Su CT; Kao CH
Anticancer Res; 2005; 25(2B):1421-6. PubMed ID: 15865100
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of metabolic tumor volume assessed by 18F-FDG PET/CT added to SUVmax for characterization of thyroid 18F-FDG incidentaloma.
Kim BH; Kim SJ; Kim H; Jeon YK; Kim SS; Kim IJ; Kim YK
Nucl Med Commun; 2013 Sep; 34(9):868-76. PubMed ID: 23797273
[TBL] [Abstract][Full Text] [Related]
11. Is it possible to predict malignancy in cases with focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography?
Fujii T; Yajima R; Yamaguchi S; Tsutsumi S; Asao T; Kuwano H
Am Surg; 2012 Jan; 78(1):141-3. PubMed ID: 22273333
[No Abstract] [Full Text] [Related]
12. Positron emission tomography (PET) positive thyroid incidentaloma: the risk of malignancy observed in a tertiary referral center.
Chu QD; Connor MS; Lilien DL; Johnson LW; Turnage RH; Li BD
Am Surg; 2006 Mar; 72(3):272-5. PubMed ID: 16553132
[TBL] [Abstract][Full Text] [Related]
13. Focal thyroid incidentaloma on whole body fluorodeoxyglucose positron emission tomography/computed tomography in known cancer patients: A case-based discussion with a series of three examples.
Targe M; Basu S
J Cancer Res Ther; 2015; 11(4):1029. PubMed ID: 26881609
[TBL] [Abstract][Full Text] [Related]
14. Thyroid incidentalomas discovered on positron emission tomography CT scanning - Malignancy rate and significance of standardised uptake values.
Brindle R; Mullan D; Yap BK; Gandhi A
Eur J Surg Oncol; 2014 Nov; 40(11):1528-32. PubMed ID: 24915858
[TBL] [Abstract][Full Text] [Related]
15. Thyroid incidentaloma identified by ¹⁸F-fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT): clinical and pathological relevance.
Pagano L; Samà MT; Morani F; Prodam F; Rudoni M; Boldorini R; Valente G; Marzullo P; Baldelli R; Appetecchia M; Isidoro C; Aimaretti G
Clin Endocrinol (Oxf); 2011 Oct; 75(4):528-34. PubMed ID: 21575027
[TBL] [Abstract][Full Text] [Related]
16. Risk stratification and prediction of cancer of focal thyroid fluorodeoxyglucose uptake during cancer evaluation.
Kim BH; Na MA; Kim IJ; Kim SJ; Kim YK
Ann Nucl Med; 2010 Dec; 24(10):721-8. PubMed ID: 20830537
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of incidental thyroid nodules on 18F-fluorodeoxyglucose positron emission tomography imaging: are these significant?
Sharma SD; Jacques T; Smith S; Watters G
J Laryngol Otol; 2015 Jan; 129(1):53-6. PubMed ID: 25496842
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of thyroid incidentalomas identified by 18F-FDG PET/CT: correlation of ultrasonograpy findings with cytology results.
Demir Ö; Köse N; Özkan E; Ünlütürk U; Aras G; Erdoğan MF
Nucl Med Commun; 2016 Jul; 37(7):715-20. PubMed ID: 26963467
[TBL] [Abstract][Full Text] [Related]
19. Correlation of BRAF mutation and SUV
Ozderya A; Temizkan S; Gul AE; Ozugur S; Sargin M; Aydin K
Endocrine; 2017 Jan; 55(1):215-222. PubMed ID: 27696232
[TBL] [Abstract][Full Text] [Related]
20. Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography.
Cohen MS; Arslan N; Dehdashti F; Doherty GM; Lairmore TC; Brunt LM; Moley JF
Surgery; 2001 Dec; 130(6):941-6. PubMed ID: 11742321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
